Backs the full 110–125% target now — ATR compression after a golden cross and re-accelerating MACD resolves directionally, and the yield surge is "last week's headline" the stock already absorbed. Waiting for confirmation above $230.10 just means paying up or missing the gap.
Treats the working-capital build and new debt as the footprint of shipping into unprecedented demand, not distress; wants the first tranche at roughly half target with the $215.50 stop as the sole risk control.
Agrees the technicals argue for participation but caps the target at a standard single-name allocation rather than overweight, given the rates shock, incomplete macro data, and a resistance level (230.10) that already rejected once.
Proposes an initial tranche of 40–50% of a standard allocation at $225.07, a single add trigger (breakout above $230.10, not both breakout and pullback), and the $215.50 stop — reassess once valuation/macro data are available.
Rejects the 110–125% target and the ~55–63% first tranche outright: the stock is stalling below a level that rejected it once (8.3% drawdown), the 30-year yield is at a generational high, and cash conversion/new debt are unresolved flags — not enough data to justify overweight size.
Wants a 25–35% probe at most, added to only on a confirmed high-volume close above $230.10, with the full build paused until valuation and fresh macro data are available.
Thesis: The fundamentals case is the strongest evidence in the debate — 105.9% YoY revenue growth, 74.7% gross margins, ~65–66% operating margins, ~$127B TTM free cash flow, and ~55x FCF-to-interest coverage. The recent selloff was a macro event, not a company event: the news window held zero NVDA-specific negative catalysts, with NVDA trading as a high-beta rate proxy while the 30-year Treasury hit post-2004 highs. Technicals are constructive without euphoria (confirmed uptrend, momentum resetting, ATR compressing), and sentiment (5.4/10, retail losses, rotation chatter) reads as a wall of worry rather than a crowded top. Against this: real rate sensitivity, an unaddressed cash-conversion/debt flag (~$25B of new long-term debt issued alongside the yield spike), and no P/E or forward multiple quoted by either side of the debate — reasons to build gradually, not reasons to hesitate on direction.
Action: build toward an overweight position gradually over 3–6 months, sized so any existing holdings are accounted for first. Deploy an initial tranche of roughly 25–35% of a standard single-name allocation, with a single add trigger — a high-volume close above $230.10 — rather than adding on both strength and weakness. Risk-manage with an ATR-scaled stop (ATR 5.86; 1.5–2x ATR ≈ 8.8–11.7 points); the trader's plan anchors a hard stop at $215.50, and each tranche must be sized so a stop-out costs no more than the standard single-name risk budget. Re-check sizing before completing the full build if valuation data becomes available, and treat a one-week alpha window (NVDA +2.2% raw) as weak confirmation only, not a reason to inflate conviction.